Medscape Medical News
- Alert FDA Approves Oral Therapy for Myelodysplastic Syndromes, CMML
- Alert FDA OKs First-in-Class HIV Therapy for Patients With Few Options
- Alert Pembro Approved for 1st-Line Use in MSI-H/dMMR Colorectal Cancer
- Alert FDA Approves In-home Breast Cancer Treatment
- Alert FDA Approves First Oral Somatostatin Analog for Acromegaly
- Alert FDA Okays New Treatment for Dravet Syndrome
- Alert FDA Approves Metoclopramide Nasal Spray for Diabetic Gastroparesis
- Alert FDA OKs Implantable Neurostimulator for Intractable Low Back Pain
- Alert FDA Gives Thumbs Up to Tazemetostat for Follicular Lymphoma
- Alert FDA Approves First Drug for Adult-Onset Still's Disease
- Alert FDA Approves Cosentyx for Treatment of Active nr-axSpA
- Alert FDA Approves Lilly's Ultra-Rapid-Acting Insulin, Lyumjev
- Alert FDA Approves Video Game-Based Therapy for Kids With ADHD
- Alert FDA OKs First Dispersible Form of Dolutegravir for Infants
- Alert FDA Clears Next-Generation Libre Glucose Monitor for Diabetes
- Alert 'Biosimilar' Insulin Glargine, Semglee, Approved for Diabetes in US
- Alert FDA OKs Ticagrelor (Brilinta) for DAPT in High-risk Stable CAD
- Alert FDA Issues Emergency Use Authorization for Impella RP in COVID-19
- Alert FDA Approves Drug Combo for Heavy Bleeding Related to Fibroids
- Alert FDA Okays First Tau Radiotracer to Aid Alzheimer's Diagnosis